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Background: Azadirachta indica (Neem) has been 
used traditionally for many centuries. Some impressive 
therapeutic qualities have been discovered. Aim: Our 
study aims to investigate the in vivo antitumor and an-
tioxidant activities of Ethanolic Neem Leaf Extract 
(ENLE) and its fraction called Nimbolide, a limonoid 
present in leaves and flowers of the neem tree 
(Azadirachta indica). Also, to study the side effects of 
the ethanolic Neem leaf extract and Nimbolide fraction 
on the liver and kidney. Materials & Methods: We 
assessed the effect of nimbolide and ethanolic Neem 
leaves extract (ENLE) on replicative lifespan prolon-
gation in vitro and on the levels of malondialdehyde 
(MDA), nitric oxide (NO), catalase, glutathione perox-
idase (GPx), Caspase-3, and Cytochrome c. Also, our 
study estimated their effect on Alanine Aminotransfer-
ase (ALT), Aspartate Aminotransferase (AST), Total 
Protein (TP), Albumin (Alb), bilirubin, urea and creati-
nine. Results: Ethanolic neem leaves extract and nim-
bolide resulted in increases in replicative lifespan. Al-
so, they showed a significant decrease in malondialde-
hyde and nitric oxide and an increase in catalase, gluta-
thione peroxidase, caspase-3 activities, and cyto-
chrome c concentration. Hence, it may be possible that 
Nimbolide and ENLE decrease lipid peroxidation level 
due to their antioxidant effect and enhance apoptosis. 
The Neem leaves extract and nimbolide showed no 
side effects on liver and kidney. Also, they showed a 
significant protection for both liver and kidney histo-
pathologically. 
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Introduction 
 
Cancer still represents one of the most serious human 
health related problems; despite the great progress in 
understanding its biology and pharmacology. Common 
therapeutic methods for cancer treatment are 
individually useful in particular situations and when 
combined with other remedies, they can offer a more 
efficient treatment. An analysis of a number of 
chemotherapeutic drugs and their sources indicates that 
over 60% of approved drugs are derived from natural 
compounds (Schottenfeld 2015). Antioxidants are 
substances that are believed to protect cells from 
becoming cancerous by stabilizing unstable molecules, 
known as free radicals. Untill now various studies have 
focused on this relationship between antioxidants and 
cancer; and these studies have produced various 
results. The disparity between their conclusions has led 
some people within the scientific community to 
question the efficacy of using antioxidant 
supplementation when attempting to combat or prevent 
cancer (Schumacker  2015, Basu et al. 2018).  
 In recent years, considerable effort has been 
directed towards identifying naturally occurring 
substances that can protect against oxidative stress 
(Maha et al. 2015). Natural antioxidants have a wide 
range of biochemical activities, including inhibition of 
ROS generation, direct or indirect scavenging of free 
radicals and alteration of intracellular redox potential 
(Azman et al. 2015). Plants are a natural source, 
producing a wide number of bioactive chemical 
constituents in a most efficient way and with precise 
selectivity. Since the middle of the 19th century, 
different classes of bioactive compounds have been 
isolated and characterized. Many of these are now used 
as active ingredients in modern medicine, or as lead 
compounds for new drug discovery. Several plant 
derived medicines are rich in phenolics, flavonoids, 
terpenoids, alkaloids, tannins etc., used in the 
treatment of various ailments (Dubey  2015). 
 Azadirachta indica (Neem) which is known as 
“the mother” of all therapeutical plants has been used 
extensively many decades ago and still been using for 
ritual and medicinal purposes. It’s availability and low 
cost has allowed many people to benefit from this 
plant. Several studies have been done from the leaves 
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up to its bark to explore its therapeutical potentials. 
The phytochemical components such as Azadirachtin, 
Nimbidin, Nimbin, Nimbinin, Nimbidinin, Nimbolide, 
Nimbidic acid, Nimbidin and Sodium Nimbidate 
derived from the Neem plant, possess a variety of 
pharmacological effects such as antipyretic, antiviral, 
antioxidant, analgesic, antibacterial, contraceptive as 
well as hepatoprotective (More et al. 2015). 
 
Materials and Methods  
 
Plant materials and extraction 
Leaves of Azadiracthta indica were collected from Al-
Qanater Al-Khaireia, Egypt in 2012 and were 
identified and characterized by Herbarium of Botany 
department, Cairo University. The leaves were dried 
and grounded into a uniform powder using a milling 
machine. Neem extract was prepared according to 
Chattopadhyay (1998). The extract was suspended in 
normal saline to obtain its final concentration 
(Subapriya et al. 2005). Extraction of nimbolide was 
prepared according to Markmee & Saiin (2003). 
 
Animals 
120 adult female Swiss albino mice weighing 22-25 g 
were purchased from the Animal House Colony of the 
National Research Center, Dokki, Giza, Egypt. The 
animals were housed at the experimental animal house 
of the Faculty of Science, Zagazig University. The 
animals were maintained in a controlled environment 
of temperature, humidity, light, and fed on a 
commercial standard diet and tap water ad libitum. 
 
Ehrlich ascites carcinoma cells 
EAC cells were initially supplied from the National 
Cancer Institute, Cairo, Egypt and maintained in 
female Swiss albino mice through serial intraperitoneal 
(I.P.) inoculation of 0.2 ml of freshly drawn ascites 
fluid (diluted to 1:5 saline solution). Each inoculum 
contained approximately 2.5 ×106 cells. This process 
was repeated every 10 days for keeping the strain 
available throughout the present study (Fahim et al. 
1997). 
 
Neem extract and nimbolide identification 
 
H1 NMR, C13 NMR and Mass spectrum 
The H1 NMR and C13 NMR spectra were recorded 
using Jeol instrument (Japan), at 270 and 125 MHz 
respectively. The Mass spectrum was recorded on a 
GCMS-QP 1000 ex spectra mass spectrometer 
operating at 70 ev. The analyses were carried by the 
Microanalytical Data Unit at the National Research 
Center, Giza, Egypt according to Subapriya et al. 
(2005).  
 
High Performance Liquid Chromatography 
High Performance Liquid Chromatography (HPLC) 
analysis of ENLE and nimbolide was performed at the 
National Research Center, Giza, Egypt according to 
Markmee & Saiin (2003). 
 
Toxicity study and dose response curve  
The approximate LD50 of Neem extract was 
determined according to Meier & Theakston (1986). 
The dose response curve for ENLE in mice was 
determined according to Crump et al. (1976). Studies 
were carried out for determination of the most 
effective dose on tumor volume and count. The LD50 
value of a single i.p. administration of nimbolide to 
adult female was 225 mg per kg of body weight 
according to Rojanapo et al. (1985). One tenth of 
LD50 was used in this work, as it is the most effective 
dose of nimbolide, reported by Gupta et al. (2013). 
 
Experimental design 
Ninety adult female albino mice were divided into six 
groups (each contained 15 mice). Group I: (Negative 
control): 15 mice injected i.p. with sterile saline 
solution (0.9 NaCl) for 9 days. Group II: (Positive 
control): 15 mice were injected i.p. with EAC cells 
2.5×106 cells/0.2 ml once for 9 days. Group III: 
Therapeutic group of ENLE: 15 mice were injected 
with EAC cells; 2.5×106 cells/0.2 ml before 
inoculation with 5 mg/Kg body weight. ENLE 
treatment day by day for 9 days. Group IV: Preventive 
group of ENLE: mice were injected with ENLE 
treatment before inoculation with EAC cells; 2.5×106 
cells/0.2 ml were used. Mice received 5 mg/Kg body 
weight. ENLE treatments day by day for 9 days. 
Group V: Therapeutic group of Nimbolide: 15 mice 
were injected i.p. with EAC 2.5×106 cells/0.2 ml 
before inoculation with 22.5 mg Nimbolidecckg b.w 
according to  Gupta et al. (2013) for 9 days. Group VI: 
Preventive group of Nimbolide: 15 mice were injected 
with 22.5 mg Nimbolide / kg body weight; they were 
then injected once with EAC cells (2.5×106 cells/0.2 
ml) for 9 days. 
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Figure 1. (a) Structure of nimbolide. (b) Dose response 
curve of total Neem extract . 
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Blood Sampling and preparation 
At the end of the experimental period, plasma was 
collected on anticoagulant (EDTA) by centrifuging 
blood at 3000 rpm for 10 minutes to carry out 
antioxidant assays (MDA, NO, Catalase and GPx). 
Serum was collected into a plain tube for 
determination of liver function tests (ALT, AST, T.P, 
albumin and bilirubin) and kidney function tests (urea 
and creatinine). 
 
Tissue sampling 
EAC cells were harvested from the peritoneal cavity of 
each mouse and suspended in sterile isotonic saline for 
the evaluation of antiapoptotic activity (Caspase-3 and 
Cytochrome c). Liver and kidney tissues were excised 
and fixed in 10% formal saline, embedded in paraffin, 
sectioned and stained with Hematoxylin and Eosin 
(H&E) for histopathological evaluation. 
 
Viability and life span prolongation 
The viability of EAC cells was determined by the 
Trypan Blue Exclusion Method (McLimans et al. 
1957), where the total and viable cells (non-stained) 
were counted at magnification ×40; as the number of 
cells/ml was determined in the studied groups. 
Replicative life span calculation was carried out 
according to the method described by Mazumdar et al. 
(1997). 
 
Biochemical  analyses 
The levels of Malondialdehyde (MDA) were 
measured according to Satoh (1978), Nitric Oxide 
(NO) was determined according to Montgomery & 
Dymock (1961), catalase enzyme activity (CAT) was 
estimated according to Aebi (1984) and Glutathione 
Peroxidase GPx activity was measured according to 
Paglia & Valentine (1967). The activity of caspase-3 
was determined by the colorimetric caspase-3 kit 
according to the method of Casciola-Rosen et al. 
(1996) while Cytochrome c was determined 
according to Cai et al. (1998). Total protein and 
albumin were measured according to Doumas et al. 
(1981), Alanine Aminotransferase (ALT) and 
Aminotransferase (AST) were determined according 
to Reitman & Frankel (1957). Serum bilirubin was 
determined according to Jendrassik & Gróf (1938). 
Urea was measured by Chaney & Marbach (1962)  
and creatinine was measured according to Murray & 
Kaplan (1984). 
 
Statistical Analysis 
All statistical analyses were done by SPSS 14.0, SPSS 
Inc. and considered statistically significant at a two-
sided P < 0.05. Numerical data were expressed as 
mean ± SD. The levels of markers were analyzed by 
ANOVA but the Mann-Whitney U-test was used for 
comparisons between independent groups (Levesque 
2007). 
 
Results 
 
Total extract and nimbolide yield 
Following extraction, Neem leaves powder (0.5 Kg 
yielded 15.8 g of ethanolic Neem leaf extract (a thick 
green paste) and another 0.5 Kg of leaf powder yielded 
1 g of Nimbolide (off-white solid). 
 
Neem extract and nimbolide identification  
HPLC was performed for identification of the extract. 
The retention time (Rt) of standards (Azadirone, 28-
Deoxonimbolide, Nimbolide, and Quercetin) were 
4.980, 3.548, 2.971, and 7.631 with 100% area. The 
retention time (Rt) of Azadirone, 28-Deoxonimbolide, 
Nimbolide, and Quercetin in ethanolic Neem leaves 
extract were found to be 5.191, 3.790, 2.912 and 7.77 
respectively, which are matching with standards Rt 
values respectively. The amount of Azadirone, 28-
Deoxonimbolide, Nimbolide, and Quercetin in 
ethanolic Neem leaves extract, were found to be 0.4%, 
3.4%, 9.4% and 3.2% w/v, respectively. To prove the 
structure of Nimbolide, mass spectroscopy, H1 NMR 
and C13 NMR were used, as shown below. 
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Table 1. EAC count (×106 cells/ml) and T/C% among different study groups. 
Group 
Positive 
control 
Nimbolide Extract 
Therapeutic 
Group 
Preventive 
Group 
Therapeutic 
Group 
Preventive 
Group 
EAC count 2099± 1457 486± 18*** No cells 919±211*** 684±195*** 
Survival 
days 
9 14 15 16 17 
life span 
T/C% 
-- 5555% 6666% 7777% 8888% 
Data are expressed as Means ± SD (n=10) *P value <0.05 was considered significant 
*P value <0.01 was considered highly significant *** P value <0.001 was considered very highly significant  
NS *P value >0.05 was considered non-significant 
M.S (EI): m/z (%) of nimbolide: 
Molecular weight= 466 g/mol (M+·, 0.25), 402 
(C24H34O5, 0.76), 385 (C22H25O5, 14), 357 (C21H25O5, 
19), 314 (C19H22O4, 9), 283 (C17H15O4, 8), 267 
(C15H23O4, 6), 240 (C15H12O3, 4), 186 (C12H10O2, 6), 
126 (C7H10O2, 9), 97 (C5H5O2, 8), 59 (C2H3O2, 3), 43 
(C3H7, 42) . 
H1NMR (DMSO-d6, ppm) of nimbolide: 
δ= 1.12 (s, 3H, CH3-30), 1.28 (s, 3H, CH3-19), 1.39 (s, 
3H, CH3-29), 1.60 (s, 3H, CH3-18), 2.00, 1.96 (m, 2H, 
C16-H), 2.30, 3.10 (dd, 2H, C11-H), 2.86 (d, 1H, C5-
αH), 3.36 (s, 3H, COCH3), 5.80 (d, 1H, C2-H), 6.23 (d, 
1H, furan- C22-H), 7.27 (d, 1H, C3-H), 7.37 (s, 1H, 
furan- C21-H), 7.51 (d, 1H, furan- C23-H). 
 
C13 NMR (DMSO-d6, ppm) of nimbolide: 
δ = 198.46 (C-1), 126.10 (C-2), 153.51 (C-3), 49.11 (C
-4), 45.29 (C-5), 77.88 (C-6), 84.86 (C-7), 51.71(C-8), 
39.84 (C-9), 53.96 (C-10), 32.20 (C-11), 136.33 (C-
13), 130.89 (C-14), 83.04  (C-15),  40.01  (C-16),  
45.29  (C-17), 14.79 (C-18), 17.56 (C-19), 110.84, 
125.32, 139.36, 143.84 (C-furan), 176.36 (C-28), 
23.15 (C-29), 18.50 (C-30), 171.76 (C=O, acetate ), 
53.90 (CH3-acetate). 
 
For determination of the median lethal dose (LD50) of 
ENLE, all doses up to 2000 mg/Kg mice were found to 
be nontoxic as no deaths were recorded, which 
suggests that ENLE may be a safe mixture. For dose- 
response curve, 5 mg ENLE/Kg mice was found to be 
the most effective dose as it reduced the number of 
EAC cells in the treated mice group to 76% compared 
to positive control mice group as shown in Figure 1. 
 
Viability and life span prolongation 
Our results demonstrated that ENLE and nimbolide 
from Neem leaves display anticancer activity as they 
decreased EAC count in mice bearing EAC in all 
groups (p<0.001) compared to positive control mice. 
Also both showed significant increase in life span in 
all studied groups compared to positive control group 
(Table 1). 
 
Biochemical Analyses 
 
Antioxidant assay 
The effects of extract and nimbolide on antioxidants 
were examined. Data in Table 2 showed that 
administration of ethanolic extract revealed a 
significant decrease in malondialdehyde (MDA) and 
nitric oxide (NO) levels (p<0.001) in therapeutic and 
preventive groups. It also showed a significant 
increase in activities of catalase and glutathione 
peroxidase enzymes in the same groups (p<0.001). In 
addition, it showed that administration of nimbolide 
resulted in significant decrease in malondialdehyde 
(MDA) and nitric oxide (NO) levels (p<0.001) in the 
therapeutic and preventive groups. It also showed 
significant increase in activities of catalase and 
glutathione peroxidase enzymes in the same groups 
(p<0.001). 
 
Apoptotic effect 
Data in Table 3 show that administration of the extract 
causes a significant increase in Caspase-3 activity and 
Cytochrome C concentration in both the therapeutic 
and preventive groups (p<0.001). Also, nimbolide 
administration showed significant increase in Caspase-
3 and Cytochrome C activities in the therapeutic group 
(p<0.001). 
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Table 2. Collective table of antioxidant parameters among different study groups. 
Group MDA(nmol/ml) NO(μmol/l) Catalase(U/L) 
Glutathione 
peroxidase(U/L) 
Negative control 1199± 079* 1984± 111*** 22737±1210*** 20037± 463*** 
Positive control 4274± 180 3442± 333 15092± 611 10244± 348 
Therapeutic Nimbolide 1203± 054*** 1327± 191*** 71716± 4886*** 61448± 1953*** 
Preventive Nimbolide 13± 075*** 1821± 138*** 90945± 5107*** 77341± 6273*** 
Therapeutic extract 1961± 145*** 2297± 124** 35338± 3560*** 35794± 3680*** 
Preventive extract 1404± 037*** 2095± 133*** 45408± 6819*** 43949± 5510*** 
Group Caspase-3(ng/ml) 
(ng/ml)
Cytochrome c 
Positive control 0834± 006 1061± 009 
Therapeutic  
Nimbolide 
3462± 022*** 474± 035*** 
Therapeutic  
Extract 
2188± 014*** 248± 028*** 
Preventive  
Extract 
2956± 024*** 332± 036*** 
Table 3. Collective table of apoptosis parameters among 
different study groups 
Liver function tests 
Data from Table 4 showed that ENLE administration 
in mice lowered AST in the therapeutic and preventive 
group (p<0.001), ALT activities (p<0.001) and 
bilirubin levels (p<0.001) compared to the positive 
control group. Data also showed an insignificant 
increase in T.P and albumin activity, compared to 
positive controls, while these values are within normal 
range after administration of the extract. In addition, 
administration of nimbolide showed a significant 
decrease in AST (p<0.001), ALT (p<0.001) and 
bilirubin (p<0.001) compared to the positive control 
group but these values are within normal range in 
mice. Data also showed a significant increase in T.P 
levels (p<0.001) and albumin activity (p<0.001) 
compared to positive control, while, again, these 
values are within normal range after administration of 
nimbolide. 
 
Kidney function tests 
Our study showed that administration of ENLE 
significantly decreased urea (p<0.001) and creatinine 
levels (p<0.001) in all studied groups, while these 
values remain within the normal range. Administration 
of nimbolide had the same effect. 
 
Histopathological examination 
The two vital organs (livers and kidneys) were 
removed from the test groups at the end of the study 
and carefully observed macroscopically. No 
observable gross lesions were identified, when 
compared with the control group. Microscopically 
however, the two organs of the test groups revealed 
some histological changes compared to the negative 
control group. 
 
Correlations between different parameters among 
study groups 
To confirm our results, correlations between 
parameters in the studied groups were done. Among 
ENLE studied groups there were strong positive 
correlations between MDA and NO (r= 0.95) (P<0.01), 
GPx and Catalase as well as Cytochrome c (r= 0.9 and 
0.8, respectively) (p<0.01), Caspase-3 with 
Cytochrome C and catalase (r= 0.97 and 0.84, 
respectively) (p<0.01) and catalase with Cytochrome C 
(r= 0.82) (p<0.01). Also there were strong negative 
correlations between MDA and GPx as well as 
Catalase (r= -0.6 for both cases) (p<0.01), NO and 
GPx as well as Catalase (r= -0.6 for both) (p<0.01). 
Among nimbolide studied groups, there were strong 
positive correlations between MDA and NO (r= 0.92) 
(P<0.01), GPx and Catalase, Caspase-3 and 
Cytochrome c (r= 0.99, 0.95 and 0.97 respectively) 
(p<0.01) and Caspase with Cytochrome c (r= 0.99) 
(p<0.01). Also there were strong negative correlations 
between MDA and GPx as well as Catalase (r= -0.6 in 
both cases) (p<0.01), NO and GPx, Catalase, Caspase-
3 and Cytochrome c (r= -0.7, -0.7, -0.5, -0.5, 
respectively) (p<0.01). 
 
Discussion 
 
Cancer is a term used to describe a group of diseases 
that cause the uncontrolled growth, invasion, and 
spread (metastasis) of abnormal cells. It is caused by 
external factors such as environmental conditions, 
radiation, infectious organisms, poor diet, lack of 
exercise, and tobacco use, as well as internal factors 
such as genetics, mutations, and hormones (Peter  
2008). Extracts of neem leaf have been reported to be 
non-toxic and non-mutagenic and have been found to 
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Table 4. Collective table of Liver function tests among different study groups 
Table 5. Collective table of kidney function tests among 
different study groups. 
Group AST(U/L) ALT(U/L) 
Total 
protein(g/dl) 
Albumin(g/dl) Bilirubin(mg/dl) 
Negative 
control 
813±236*** 415±233*** 686±012*** 263±011*** 0387±004*** 
Positive 
control 
1097±462 113± 807 55± 031 178± 016 0944± 005 
Therapeutic 
Nimbolide 
552±271*** 355±322*** 691±013*** 277±017*** 0201±006*** 
Preventive 
Nimbolide 
417±517*** 238±318*** 676±020 282±013*** 0138±005*** 
Therapeutic 
extract 
1028±799 757±533*** 585±032** 221±014* 0289±006*** 
Preventive 
extract 
845±338*** 735±443*** 632±034* 223±012* 0415±007*** 
Group Urea(mg/dl) Creatinine(mg/dl) 
Negative control 21± 397*** 0385± 017*** 
Positive control 621± 338 1663± 016 
Therapeutic Nimbo-
lide 
***249± 221 0903± 006*** 
Preventive Nimbo-
lide 
205± 272*** 0758± 009*** 
Therapeutic extract 292± 124*** 0658± 010*** 
Preventive extract 316± 162*** 0509± 009*** 
possess immunomodulatory as well as anti-
inflammatory and anticarcinogenic properties 
(Subapriya & Nagini 2005). There are many studies 
showing that the ethanolic extract of Neem leaves 
possess anticancer activity. Ethanolic Neem leaf 
extract (ENLE) has exhibited anticancer activity 
against N-methyl-N'-nitro-N- nitrosoguanidine-
induced oxidative stress and gastric carcinogenesis 
(Subapriya & Nagini 2003). ENLE has been reported 
to induce apoptosis in a-prostate cancer cell line (PC-
3) by up-regulating the pro-apoptotic protein Bax and 
decreasing the level of Bcl-2 protein resulting in DNA 
fragmentation in prostate cancer cells (Kumar et al. 
2006, Gunadharini et al. 2011). Many bioactive 
compounds are isolated from this plant including 
nimbolide, which belongs to the limonoid group. 
Nimbolide is a major component of Neem leaves and a 
tetranortriterpenoid that consists of a classic limonoid 
skeleton with an α, β-unsaturated ketone system and a 
δ-lactone ring (Anitha et al. 2007). Nimbolide has 
numerous types of biological activity, including 
antimalarial and anticancer activity (Roy et al. 2007). 
It has been was found to exhibit anticancer activity in a 
wide variety of tumor cells, including neuroblastoma, 
osteosarcoma and choriocarcinoma (Phillips et al. 
2006), leukemia (Gerhauser 2008), melanoma cells as 
well as macrophages (Neto 2007). ENLE contains a 
number of antioxidants and anticarcinogens including 
terpenoids, limonoids, quercetin and sitosterols. 
Constituents of Neem leaf such as nimbolide, 28-
deoxonimbolide and azadirone have been found to 
possess cytotoxic activity against various cancer cell 
lines (Naundri et al. 2003). Quercetin, a highly ethanol 
soluble Neem bioflavonoid and potent antioxidant has 
been reported to inhibit the growth of tumor cells in 
malignant cell lines and down regulate the expression 
of Bcl-2 and mutant p53 protein (Nguyen et al. 2004). 
Similarly, 28-Deoxonimbolide exhibited potent 
cytotoxic activities against HL60 cells (Kikuchi et al. 
2011) and showed high cytotoxicity against a normal 
lymphocyte cell line (Pati et al. 2008). The LD50 of 
nimbolide was reported to be 225 mg∕Kg body weight 
in mice according to Crump et al. (1976) whereas 
Glinsukon et al. (1986) reported it to be 280 mg∕Kg 
body wt. This difference was proposed to be due to 
individual variation (Casarez 2001).  
 In this regard, the acute   toxicity   was   
estimated   by intraperitoneal administration of ENLE 
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Figure 2.  Liver and kidney H&E photo-
micrographs. (a) Photomicrograph from 
the liver “negative control” group showing 
normal healthy hepatic parenchyma and 
(b) from the liver “positive control” group 
showing a focal large area of necrotic cells 
[N] infiltrated with mononuclear cells [M]. 
(c): Photomicrograph of liver "extract pre-
ventive and therapeutic” groups showing 
healthy hepatic parenchyma and (d) photo-
micrograph from the liver "Nimbolide 
preventive and therapeutic” groups show-
ing healthy hepatic parenchyma. (e) Photo-
micrograph from kidney “negative con-
trol” group showing normal glomeruli and 
renal tubules. (f) Photomicrograph from 
kidney “positive control” group showing 
infiltration of mononuclear cells [M]. (g) 
Photomicrograph from kidney “extract 
preventive and therapeutic” groups show-
ing normal glomeruli and renal tubules 
while (h) shows normal glomeruli and 
renal tubules from kidney “Nimbolide 
preventive and therapeutic” groups. 
(a) (b) 
(c) (d) 
(e) (f) 
(g) (h) 
to determine the median lethal dose (LD50). Our 
results revealed that a dose up to 2000 mg /kg was 
considered safe. In addition, we show that 5 mg /kg is 
considered to be the most effective dose of ENLE. Our 
results are in agreement with Ghimeray  et al. (2009) 
who reported that toxicological investigation of A. 
indica leaf extracts at 0.6 - 2.0 g/kg body weight did 
not possess any lethal effects on hematology, enzyme 
levels and affect any histopathological parameters of 
experimental animals. For the evaluation of 
antiproliferative activity of the ethanolic extract and 
nimbolide, it has been demonstrated that nimbolide 
and ENLE from the Neem tree have anticancer 
activity, as they decreased EAC count in mice in all 
treated groups. There was complete absence of tumor 
cells in the nimbolide preventive group. ENLE 
decreased cell proliferation through the inhibition of 
the Insulin-like growth factor (IGF) signaling 
molecules in both MCF-7 and MDA MB-231 cells 
(Elumalai et al. 2012). Another study proved the 
antiproliferative activity of ethanolic Neem leaves 
extract (ENLE) alone or in combination with cisplatin 
by cell viability assay on human breast (MCF-7) and 
cervical human epithelial adenocarcinoma cells (HeLa) 
(Chhavi et al. 2014). The therapeutic dose was found 
to be 22.5mg/Kg body weight, which is one tenth of 
the LD50 and the effective dose according to Rojanapo 
et al. (1985) who reported that administration of 
nimbolide at 20 mg/kg of body weight reduced tumor 
growth by almost 90% of human colorectal cancer 
xenografts, further supporting our results. Nimbolide 
has effectively inhibited proliferation of WiDr colon 
cancer cells and has been shown to exert its 
antiproliferative effects in various cell lines 
(Babykutty et al. 2011). Also, Roy et al. (2007) 
suggested that Nimbolide, a triterpenoid extracted 
from the flowers of the Neem tree was found to have 
antiproliferative activity against some cancer cell lines.  
 Living organisms possess intrinsic antioxidant 
defense mechanisms against free radicals, which are 
sufficient to prevent oxygen radical cytotoxic effects 
(Yoshikawa & Naito 2002). In our study MDA, NO 
and other major antioxidants were chosen as lipid 
peroxidation indicators. Our results showed a 
significant decrease in MDA and NO levels while an 
increase in the activities of catalase and glutathione 
peroxidase was shown. Hence, it may be possible that 
ENLE and nimbolide decrease lipid peroxidation level 
due to their antioxidant effect. Our results agree with 
Dutta et al. (2011) who suggested that Neem leaf 
aqueous extract exhibited significant free radical 
scavenging. Another study showed an increase in 
MDA and NO levels after treatment with the 
methanolic leaves extract of Azadirachta indica 
(MLEN, 500 mg/Kg b.w) on cisplatin- (CP) induced 
nephrotoxicity and oxidative stress in rats. However, 
the oral administration of MLEN to CP-intoxicated 
rats for 5 days brought back MDA, NO production, 
and enzymatic and non-enzymatic antioxidants to near 
normal levels (Ahmed et al. 2014).  
 Neem leaf extract has been shown to enhance 
the activity of GPx in various tissues of mice and rats 
(Dasgupta et al. 2004). Another study has shown that 
the extract elevated GPx activity in benzo(a)pyrene-
induced forestomach tumorigenesis in mice (Gangar et 
al. 2006). GPx activity was significantly increased in 
the stomach after treatment with ethanolic Neem leaf 
extract against N-methyl -N’- nitro-N nitrosoguanidine
-induced gastric carcinogenesis in Wistar rats 
(Subapriya & Nagini 2005). This may be attributed to 
enhanced antioxidant capacities. Increased generation 
of ROS such as O2
•- and H2O2 is recognized to induce 
CAT and GPx. Higher activities of antioxidant 
enzymes have been observed in malignant tumors 
compared to controls (Kumaraguruparan et al. 2002). 
 Similarly, apoptosis is an ordered and 
orchestrated cellular process that occurs in 
physiological and pathological conditions. Apoptosis 
plays an important role in the treatment of cancer as it 
is a popular target of many treatment strategies (Wong 
2011). Caspase-3 is also required for some hallmarks 
of apoptosis (Porter & Jänicke 1999). Cytochrome c is 
also involved in the initiation of apoptosis. 
Cytochrome c was reported to be higher in cancer 
tissues than in non-diseased organs (Sánchez-Alcázar 
et al. 2000). Our results showed significant increase in 
Caspase-3 activity and Cytochrome c level compared 
with the positive control group. Elumalai et al. (2012) 
has previously shown that nimbolide activates caspase 
3. Also, the mitochondrial pathway is engaged by the 
release of apoptogenic factors like cytochrome c from 
the mitochondrial inter membrane space into the 
cytosol. Additionally, NLE treatment-induced 
morphological apoptotic changes have been associated 
with increased caspase-3 in oocytes (Anima et al. 
2011). Our study is in agreement with Gupta et al. 
(2011), who reported that nimbolide increases 
Cytochrome c levels while treating human colon 
cancer cells with Neem extract and suggested that it is 
a controlled form of cell death.  
 Liver is the most important key organ in the 
metabolism, detoxification and secretary functions in 
the body and it is highly affected primarily by toxic 
agents. In this regard, the following parameters were 
studied for assessment of liver damage: Aspartate 
aminotransferase (AST), Alanine aminotransferase 
(ALT), Total protein (T.P), Albumin (Alb) and 
Bilirubin (Baligar et al. 2014). Our study showed that 
ethanolic Neem leave extract and nimbolide have no 
significant changes in all parameters in the studied 
groups, highlighting the non-hepatotoxic nature of 
Neem extracts. These results are in agreement with 
Haque et al. (2006), who found unaltered and normal 
activities of serum ALT and AST following 
prophylactic treatment on Swiss albino mice with 
neem leaf preparation against Ehrlich's carcinoma. 
Also, Bhanwra et al. (2000) reported the 
hepatoprotective role of Neem leaves extract against 
Journal of Molecular Biochemistry, 2019   21 
paracetamol-induced hepatic damage in albino rats as 
indicated by stable serum activity of ALT and AST 
and histopathological observations of liver tissues. 
Similarly, the extract has been reported to prevent 
changes in the serum levels of bilirubin, total protein, 
alanine aminotransferase and aspartate 
aminotransferase after induction with antitubercular 
drugs in albino rats (Kale et al. 2003).  
 Concerning the kidneys, our results showed 
insignificant decreases in urea and creatinine levels 
with respect to the positive control group, while these 
values are within normal range. Mallick et al. (2013) 
reported that Neem leaf glycoprotein (NLGP) is non-
toxic even in higher doses and showed apparently 
normal urea and creatinine levels. Thus, it can be 
recommended for human use in anti-cancer therapy. 
Another study investigated the protective effect of the 
leaves against cisplatin induced nephrotoxicity. They 
showed significant protection as evidenced by the 
decrease of elevated urea. This improvement of 
physiological function was associated with high 
protection against histopathological injury induced by 
cisplatin on kidney. This result suggests that neem 
leaves pre- and post-treatment can prevent the 
nephrotoxicity induced by cisplatin (Doaa et al. 2011). 
This is in accordance with another study which 
reported insignificant changes in urea and creatinine of 
aqueous Azadirachta indica leaf extract (ALE) 
(Nnenna & Okey 2013).  
 With regards to histopathology, the livers of 
the positive group showed very clear pathological 
changes, such as focal large areas of necrotic cells 
infiltrated with mononuclear cells, while the negative 
control group showed normal healthy hepatic 
parenchyma. The therapeutic and the preventive 
groups of Nimbolide and ENLE also showed normal 
healthy hepatic parenchyma as shown in Figure 2a-d. 
The kidneys of the positive group showed very clear 
pathological changes, such as mononuclear cell 
infiltration while the negative group showed normal 
glomeruli and renal tubules. The therapeutic and the 
preventive groups of Nimbolide and ENLE also 
showed normal glomeruli and renal tubules (Figure 2e-
h). It was found that histopathological changes were 
remarkably reversed in graded doses of nimbolide 
pretreated rats with lesser vacuolar degeneration and 
hepatic necrosis. Our results are in accordance with 
Baligar et al. (2014) who reported that nimbolide 
protected the liver tissue against CCl4 toxicity with 
mild hepatocellular degeneration and less 
inflammatory cell infiltration. Similarly, paracetamol-
induced liver necrosis was found to be reduced as 
observed macroscopically and histologically after 
treatment with aqueous leaf extract of A. indica 
(Bhanwra et al. 2000). To confirm our results, 
correlations between parameters in the studied groups 
were calculated.  
 In conclusion, the present study demonstrates 
that ethanolic Neem leaves extract and nimbolide 
provide a significant antiproliferative activity against 
Ehrlich ascites carcinoma cells, have potent 
antioxidant activity and induce apoptosis through 
caspase-3 and the release of cytochrome c, with no 
side effects on the liver or kidney. In addition, the 
study shows that nimbolide provides a significant 
protective effect against Ehrlich ascites. The anticancer 
activity of nimbolide could be due to the presence of 
α,β-unsaturated ketone structural elements and a δ-
lactone ring. Therefore, nimbolide could represent a 
high potential antitumoral compound. 
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